PRIORIX

Powder and solvent for solution for injection, 10exp3 CCID50/0.5ml + 10exp3.7 CCID50/0.5ml + 10exp3 CCID50/0.5ml
RxActive license

Active substance (INN)

measles, mumps and rubella vaccine, live attenuated

Pharmaceutical form

Pharmaceutical formPowder and solvent for solution for injection
Strength10exp3 CCID50/0.5ml + 10exp3.7 CCID50/0.5ml + 10exp3 CCID50/0.5ml
PackagingUkupno 1 bočica staklena sa praškom za rastvor za injekciju i 1 napunjeni injekcioni špric sa 0.5ml rastvarača u kartonskoj kutiji
ManufacturerGlaxoSmithKline Biologicals S.A., Belgium
Therapeutic groupAnti-infectives for systemic use (J07BD52)
Marketing authorization holder"EVROPA LEK PHARMA" DOO PODGORICA
Authorization dateFebruary 20, 2026

Analogs in Montenegro

2

Other medicines with the same active substance

M-M-RVAXPRORx
Powder and solvent for suspension for injection in pre-filled syringe, 1x10exp3 TCID50/0.5ml + 12Merck Sharp & Dohme B.V.
M-M-RVAXPRORx
Powder and solvent for suspension for injection in pre-filled syringe, 1x10exp3 TCID50/0.5ml + 12Merck Sharp & Dohme B.V.
Source: CInMED register